Prevalence and outcomes of familial hypercholesterolemia in young patients undergoing coronary bypass surgery

Back

ESC Professional Premium Access

Prevalence and outcomes of familial hypercholesterolemia in young patients undergoing coronary bypass surgery

Session: Risk factors and prevention: lipids (2)

Topic: Lipids

Speaker: Doctor J. Black (Hobart, AU)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor James Andrew Black

Menzies Research Institute, Hobart (Australia)

0 follower

8 more presentations in this session

Hyperlipoproteinemia(a) in coronary artery disease patients: who are patients with very high levels and how do they respond to the PCSK9 antibody therapy?

Speaker: Doctor M. Novakovic (Ljubljana, SI)

Increased triglyceride independently associates with premature structural and functional cardiac damage progression in asymptomatic adolescents: a 7-year longitudinal study

Speaker: Doctor A. Agbaje (Kuopio, FI)

Characterization of lipidic coronary atheroma under control of low-density lipoprotein <1.8 mmol/l and lipoprotein (a) <50 mg/dl in patients with coronary artery disease

Speaker: Doctor D. Shishikura (Takatsuki, JP)

Increased Lipoprotein (a) and familial hypercholesterolemia: a dangerous combination.Data from a 12-year follow-up study

Speaker: Doctor I. Andrikou (Athens, GR)

Analysis of routine molecular genetic diagnostics of familial hypercholesterolemia at tertiary care lipid clinics

Speaker: Doctor M. Ferch (Vienna, AT)

Access the full session

Risk factors and prevention: lipids (2)

Speakers: Doctor J. Black, Doctor M. Novakovic, Doctor A. Agbaje, Doctor D. Shishikura, Doctor I. Andrikou...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Prevalence and outcomes of familial hypercholesterolemia in young patients undergoing coronary bypass surgery

About the speaker

Doctor James Andrew Black

8 more presentations in this session

Hyperlipoproteinemia(a) in coronary artery disease patients: who are patients with very high levels and how do they respond to the PCSK9 antibody therapy?

Increased triglyceride independently associates with premature structural and functional cardiac damage progression in asymptomatic adolescents: a 7-year longitudinal study

Characterization of lipidic coronary atheroma under control of low-density lipoprotein <1.8 mmol/l and lipoprotein (a) <50 mg/dl in patients with coronary artery disease

Increased Lipoprotein (a) and familial hypercholesterolemia: a dangerous combination.Data from a 12-year follow-up study

Analysis of routine molecular genetic diagnostics of familial hypercholesterolemia at tertiary care lipid clinics

Access the full session

Risk factors and prevention: lipids (2)

About the event

ESC Congress 2023

ESC 365 is supported by